DPP-4 inhibitors: predicted mean absolute HbA1c change from baseline at 6 months in PRIBA (A) and CPRD (B) across subgroups defined by the presence or absence of obesity (BMI ≥30 kg/m2) and high triglycerides (TRGS) (≥2.3 mmol/L): subgroup A, nonobese and normal triglycerides; subgroup B, nonobese or normal triglycerides; and subgroup C, obese and high triglycerides. Baseline HbA1c is standardized to the mean PRIBA baseline level of 74 mmol/mol (8.9%) for all subgroups. Error bars denote 95% CI.